U.S. IPO Week Ahead: The IPO Pipeline Is Active In A 1 IPO Week

, , Comments Off on U.S. IPO Week Ahead: The IPO Pipeline Is Active In A 1 IPO Week

Phase 2 ENT biotech Lyra Therapeutics plans to raise $53 million at a $193 million market cap. US tech-focused SPAC Social Capital Hedosophia Holdings II plans …
( read original story …)